In a cross functional team setting participants will understand how to optimize a clinical development program for a successful pricing and commercialization strategy over its life cycle
They will learn
Health economics could support the purchasing and reimbursement decisions by various stakeholders in Germany. MArS and the medical device association BVMed have organized a one-day conference in November 2016 for the fourth time to discuss the different health economic tools available for different situations in the German context of medical devices. Slides and information are available on request.
Selective contracts could be the only or a timely opportunity market access solution for medical devices in Germany. MArS and the medical device association BVMed are organizing a one-day conference on July 5 2016 to discuss the different current and future perspectives of selective contracts in the German context of medical device market access in Berlin. Slides and further information are available on request.
Large and small companies both need to request and defend their investments and plan accordingly to succeed with their compounds in the future in the respective markets. MArS in conjunction with the biotechnology association Bio-M have developed a dedicated seminar on the lifecycle approach for companies including the important market access perspective.
The seminar was a big success and further information are available on request.